Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 10.97
+0.08 (0.73%)
At close: Mar 9, 2026
SHE:301301 Revenue
Yili Chuanning Biotechnology had revenue of 1.09B CNY in the quarter ending September 30, 2025, a decrease of -13.76%. This brings the company's revenue in the last twelve months to 4.74B, down -16.85% year-over-year. In the year 2024, Yili Chuanning Biotechnology had annual revenue of 5.76B with 19.38% growth.
Revenue (ttm)
4.74B
Revenue Growth
-16.85%
P/S Ratio
5.16
Revenue / Employee
1.49M
Employees
3,184
Market Cap
24.46B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 812.73M |
| Hualan Biological Engineering | 4.27B |
| Xiamen Amoytop Biotech | 3.70B |
| Beijing Tiantan Biological Products | 6.42B |
| Sinocelltech Group | 1.56B |
| BrightGene Bio-Medical Technology | 1.22B |
| Asymchem Laboratories (Tianjin) | 6.29B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.20B |